12 Month Price Forecast For GNW
Distance to GNW Price Forecasts
GNW Price Momentum
๐ค Considering Genworth (GNW)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 15, 2025 3:25 PM UTC
GNW Analyst Ratings & Price Targets
Based on our analysis of 3 Wall Street analysts, GNW has a neutral consensus with a median price target of $8.50 (ranging from $8.50 to $8.50). Currently trading at $7.29, the median forecast implies a 16.6% upside. This outlook is supported by 0 Buy, 1 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
GNW Analyst Consensus
GNW Price Target Range
Latest GNW Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for GNW.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Apr 10, 2024 | Keefe, Bruyette & Woods | Ryan Krueger | Market Perform | Maintains | $7.00 |
Jun 11, 2018 | Wells Fargo | Sean Dargan | Market Perform | Maintains | $5.00 |
Nov 11, 2016 | Compass Point | Buy | Upgrade | $0.00 | |
Oct 5, 2016 | BTIG | Neutral | Downgrade | $0.00 | |
Oct 5, 2016 | BTIG Research | Neutral | Downgrade | $0.00 | |
Sep 23, 2016 | Goldman Sachs | Neutral | Maintains | $4.00 | |
Sep 19, 2016 | Compass Point | Neutral | Downgrade | $0.00 | |
Feb 9, 2016 | UBS | Sell | Maintains | $1.75 | |
Jan 22, 2016 | UBS | Sell | Maintains | $2.25 | |
Nov 17, 2015 | Goldman Sachs | Neutral | Initiates | $0.00 | |
Nov 4, 2015 | UBS | Sell | Downgrade | $0.00 | |
Oct 5, 2015 | JP Morgan | Neutral | Maintains | $8.00 | |
Sep 17, 2015 | Macquarie | Neutral | Maintains | $7.00 | |
Sep 2, 2015 | Keefe, Bruyette & Woods | Maintains | $6.00 | ||
Sep 2, 2015 | Keefe Bruyette & Woods | Maintains | $0.00 | ||
Aug 6, 2015 | Raymond James | Outperform | Downgrade | $0.00 | |
Aug 5, 2015 | Macquarie | Neutral | Upgrade | $0.00 | |
May 28, 2015 | Morgan Stanley | Equal-Weight | Upgrade | $0.00 | |
May 15, 2015 | Keefe Bruyette & Woods | Market Perform | Maintains | $0.00 | |
May 15, 2015 | Keefe, Bruyette & Woods | Market Perform | Maintains | $8.00 |
Stocks Similar to Genworth Financial Inc
The following stocks are similar to Genworth based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Genworth Financial Inc (GNW) Financial Data
Genworth Financial Inc has a market capitalization of $3.11B with a P/E ratio of 28.0x. The company generates $7.43B in trailing twelve-month revenue with a 1.2% profit margin.
Revenue growth is +2.7% quarter-over-quarter, while maintaining an operating margin of +10.1% and return on equity of +2.4%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

Genworth Financial Inc (GNW) Company Overview
About Genworth Financial Inc
Provides mortgage and long-term care insurance products.
The company operates through three segments: Enact, Long-Term Care Insurance, and Life and Annuities. It generates revenue by offering private mortgage insurance, long-term care insurance, and various life and annuity products, primarily through a combination of a dedicated sales force, in-house representatives, and digital marketing strategies.
Founded in 1871 and headquartered in Richmond, Virginia, the company has a long-standing presence in the insurance market, catering to both individual and corporate clients with a diverse range of insurance solutions aimed at protecting against financial risks associated with healthcare and home financing.
Company Information
Sector
Financial Services
Industry
Insurance - Life
Employees
2,700
CEO
Mr. Thomas Joseph McInerney
Country
United States
IPO Year
2004
Website
www.genworth.comGenworth Financial Inc (GNW) Latest News & Analysis
Genworth Financial, Inc. (NYSE: GNW) will release its Q4 earnings on February 18, 2025, after market close, followed by a conference call on February 19 at 9:00 a.m. ET.
Genworth Financial's upcoming earnings release and conference call may impact stock performance and investor sentiment, providing insights into financial health and future guidance.
Genworth Financial, Inc. (NYSE:GNW) will hold its Q3 2024 Earnings Conference Call on November 7, 2024, at 9:00 AM ET, featuring key executives and financial analysts.
Genworth's Q3 earnings call provides insights into financial performance and strategic direction, influencing stock valuation and investor sentiment.
In October, 42 new analysts joined Seeking Alpha, offering investment ideas across sectors. Notable strong buy recommendations include MicroStrategy, CorMedix, and Vertex Pharmaceuticals.
The influx of new analysts and their strong buy recommendations can indicate growing confidence in certain stocks, potentially influencing market sentiment and investment strategies.
Genworth Financial reported its third quarter 2024 results, as announced from Richmond, Va. Further details on performance are likely to follow.
Genworth Financial's Q3 2024 results can impact stock performance, investor sentiment, and future earnings projections, influencing market strategies and investment decisions.
Genworth Financial's stock, halved over the last decade, may see a turnaround due to its 80% stake in Enact. GNW is considered undervalued, trading just above $10 per share.
Genworth Financial's potential turnaround and undervaluation, alongside its unique insurance offerings, suggest a favorable buying opportunity as market dynamics shift.
Genworth Financial, Inc. (NYSE: GNW) will release its Q3 earnings on November 6, 2024, after market close, with a conference call on November 7 at 9:00 a.m. ET.
Genworth Financial's upcoming earnings release and conference call could significantly impact its stock price, providing insights into financial health and performance trends.
Frequently Asked Questions About GNW Stock
What is Genworth Financial Inc's (GNW) stock forecast for 2025?
Based on our analysis of 3 Wall Street analysts, Genworth Financial Inc (GNW) has a median price target of $8.50. The highest price target is $8.50 and the lowest is $8.50.
Is GNW stock a good investment in 2025?
According to current analyst ratings, GNW has 0 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $7.29. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for GNW stock?
Wall Street analysts predict GNW stock could reach $8.50 in the next 12 months. This represents a 16.6% increase from the current price of $7.29. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Genworth Financial Inc's business model?
The company operates through three segments: Enact, Long-Term Care Insurance, and Life and Annuities. It generates revenue by offering private mortgage insurance, long-term care insurance, and various life and annuity products, primarily through a combination of a dedicated sales force, in-house representatives, and digital marketing strategies.
What is the highest forecasted price for GNW Genworth Financial Inc?
The highest price target for GNW is $8.50 from at , which represents a 16.6% increase from the current price of $7.29.
What is the lowest forecasted price for GNW Genworth Financial Inc?
The lowest price target for GNW is $8.50 from at , which represents a 16.6% increase from the current price of $7.29.
What is the overall GNW consensus from analysts for Genworth Financial Inc?
The overall analyst consensus for GNW is neutral. Out of 3 Wall Street analysts, 0 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $8.50.
How accurate are GNW stock price projections?
Stock price projections, including those for Genworth Financial Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.